Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Zhaoke Ophthalmology Ltd. ( (HK:6622) ) is now available.
Zhaoke Ophthalmology Limited has called its annual general meeting for May 15, 2026, in Hong Kong, where shareholders will vote on key share capital mandates. The agenda includes proposals to authorize the board to repurchase up to 10% of the company’s issued share capital, excluding treasury shares, and to grant directors broad authority to issue, allot, and deal in additional shares and related securities.
If approved, these resolutions would give the board greater flexibility in managing the company’s capital structure and conducting future financing or buy-back activities. The mandates are time-limited to the period until the next annual general meeting or earlier revocation, aligning the company with common Hong Kong market practices on share issuance and repurchase authorities.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited is a Hong Kong-listed company in the ophthalmology sector. It focuses on eye-related healthcare and operates through a share structure listed on the Stock Exchange of Hong Kong under stock code 6622.
Average Trading Volume: 652,595
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.71B
See more insights into 6622 stock on TipRanks’ Stock Analysis page.